Karl Mårild

9PUBLICATIONS
68CO-AUTHORS
Infant and child healthBehavioural epidemiologyFood properties (incl. characteristics and health benefits)Foetal development and medicineNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 06, 2026
Efficacy and safety of ustekinumab and vedolizumab in very early-onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN.

|Aug 24, 2026
Modifiable lifestyle factors in early life and inflammatory bowel disease risk in two birth cohorts.

|Jun 09, 2026
Timing of complementary food introduction is not associated with inflammatory bowel disease risk: A prospective birth cohort study.

|Mar 05, 2026
Corticosteroid Use in Childhood-Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006-2022).

Karl Mårild, Mikkel Malham, Petter Malmborg

|Jan 30, 2026
Systematic review and meta-analysis of childhood exposure to antibiotics and the subsequent risk of IBD.

Ketil Størdal, Svend Andersen, Karl Mårild

|Feb 13, 2025
Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study.

Karl Mårild, Jonas Söderling, Olof Stephansson

Pageof 2

Frequent Collaborators

3 joint publications

Ketil Størdal

2 joint publications

Ida Sigvardsson

2 joint publications

Jonas F Ludvigsson

2 joint publications

Ola Olén